First Trust Indxx Medical Devices ETF
MDEV
7 hedge funds and large institutions have $2.16M invested in First Trust Indxx Medical Devices ETF in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
2.66% more ownership
Funds ownership: 67.42% → 70.09% (+2.7%)
0% more funds holding
Funds holding: 7 → 7 (0)
4% less capital invested
Capital invested by funds: $2.25M → $2.16M (-$89.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$46K |
| 2 |
Jane Street
New York
|
+$32.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.7K |
MDEV Hedge Fund Activity: Q4 2024 in Review
7 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in First Trust Indxx Medical Devices ETF (MDEV) for Q4 2024, worth a combined $2.16M — down 4% from $2.25M a quarter earlier.
Fund positioning in MDEV was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Arax Advisory Partners, adding an estimated $46K. The largest seller was UBS Group, cutting an estimated $2.7K.
- 7 institutional investors held First Trust Indxx Medical Devices ETF (MDEV) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $2.16M of First Trust Indxx Medical Devices ETF stock for Q4 2024, down 4% quarter-over-quarter.
- 0 funds opened new First Trust Indxx Medical Devices ETF positions in Q4 2024 and 0 closed out.
- The largest First Trust Indxx Medical Devices ETF buyer in Q4 2024 was Arax Advisory Partners, an estimated $46K added.
- The largest First Trust Indxx Medical Devices ETF seller in Q4 2024 was UBS Group, an estimated $2.7K sold.
Based on aggregated 13F filings for Q4 2024.